Analysis of pellet properties with use of artificial neural networks

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 3-4, 2010, Pages 421-429

  Mendyk, Aleksander ^a   Kleinebudde, Peter ^b   Thommes, Markus ^b   Yoo, Angelina ^b   Szlêk, Jakub ^a   Jachowicz, Renata ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Artificial neural networks; Computational intelligence; Data mining; Neuro fuzzy systems; Pellets; Pharmaceutical technology

Indexed keywords

EXCIPIENT;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; DRUG FORMULATION; DRUG PELLET; PELLET EXTRUSION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPHERONIZATION;

ALGORITHMS; ALKALOIDS; DATABASES, FACTUAL; DRUG IMPLANTS; FUZZY LOGIC; ISOQUINOLINES; MODELS, CHEMICAL; NEURAL NETWORKS (COMPUTER);

EID: 77957252765     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.07.010     Document Type: Article

References (42)

1. Agatonovic-Kustrin S., Alany R.G. Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems. Pharm. Res. 2001, 18:1049-1055.
2. Amani A., York P., Chrystyn H., Clark B.J., Do D.Q. Determination of factors controlling the particle size in nanoemulsions using artificial neural networks. Eur. J. Pharm. Sci. 2008, 35:42-51.
3. Baert L., Vermeersch H., Remon J.P., Smeyersverbeke J., Massart D.L. Study of parameters important in the spheronization process. Int. J. Pharm. 1993, 31:225-229.
4. Bilski, J., 2000. The backpropagation learning with logarithmic transfer function. In: Proceedings of the Fifth Conference Neural Networks and Soft Computing. Zakopane, Poland 6-10 June 2000. Conference Materials, pp. 71-77.
5. Bornhöft M., Thommes M., Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur. J. Pharm. Biopharm. 2005, 59:127-131.
6. Bourquin J., Shmidli H., van Hoogevest P., Leuenberger H. Advantages of Artificial Neural Networks (ANNs) as alternative modeling technique for data sets showing non-linear relationship using data from a galenical study on a solid dosage form. Eur. J. Pharm. Sci. 1998, 7:5-16.
7. Bourquin J., Shmidli H., van Hoogevest P., Leuenberger H. Comparison of artificial neural networks (ANN) with classical modeling techniques using different experimental designs and data from a galenical study on a solid dosage form. Eur. J. Pharm. Sci. 1998, 6:287-300.
8. Bourquin J., Shmidli H., van Hoogevest P., Leuenberger H. Pitfalls of artificial neural networks (ANN) modeling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage form. Eur. J. Pharm. Sci. 1998, 7:17-28.
9. Brier M.E., Aronoff G.R. Application of artificial neural networks to clinical pharmacology. Int. J. Clin. Pharm. Ther. 1996, 34:510-514.
10. Brier M.E., Żurada J.M. Neural network predicted peak and trough gentamicin concentrations. Pharm. Res. 1995, 12:406-412.
11. Chow H.-H., Tolle K.M., Roe D.J., Elsberry V., Chen H. Application of neural networks to population pharmacokinetic data analysis. J. Pharm. Sci. 1997, 86:840-845.
12. Dowell J., Hussain A., Devane J., Young D. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. J. Pharm. Sci. 1999, 88:154-160.
13. Gašperlin M., Tušar L., Tušar M., Kristl J., Šmid-Korbar J. Lipophilic semisolid emulsion systems: viscoelastic behavior and prediction of physical stability by neural network modeling. Int. J. Pharm. 1998, 168:243-254.
14. Gašperlin M., Tušar L., Tušar M., Šmid-Korbar J., Zupan J., Kristl J. Viscosity prediction of lipophilic semisolid emulsion systems by neural network modeling. Int. J. Pharm. 2000, 196:37-50.
15. Ghebre-Sellassie I. Pellets: a general overview. Pharmaceutical Pelletization Technology 1989, 1-14. Marcel Dekker, New York. I. Ghebre-Sellassie (Ed.).
16. Gordon M.S., Schmidt M.W. Advances in electronic structure theory: GAMESS a decade later. Theory and Applications of Computational Chemistry, The First Forty Years 2005, 1167-1189. Elsevier, Amsterdam.
17. Hellen L., Yliruusi J., Merkku P., Kristoffersson E. Process variables of instant granulator and spheroniser. 1. Physical-properties of granules, extrudate and pellets. Int. J. Pharm. 1993, 31:197-204.
18. Hussain A.S., Johnson R.D., Vachcarajani N.N., Ritschel W.A. Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data. Pharm. Res. 1993, 10:466-469.
19. Hussain A.S., Shivanand P., Johnson R.D. Application of neural computing in pharmaceutical product development: computer aided formulation design. Drug Dev. Ind. Pharm. 1994, 20:1739-1752.
20. Hussain A.S., Yu X., Johnson R.D. Application of neural computing in pharmaceutical product development. Pharm. Res. 1991, 8:1248-1252.
21. Inghelbrecht S., Remon J.-P., de Aguiar P.F., Walczak B., Massart D.L., Van De Velde F., De Baets P., Vermeersch H., De Backer P. Instrumentation of a roll compactor and the evaluation of the parameter settings by neural networks. Int. J. Pharm. 1997, 148:103-115.
22. Jerwanska E., Alderborn G., Borjesson E., Newton J.M., Nystrom C. Effect of water content on tensile fracture force and deformability of ram extruded cylinders. Int. J. Pharm. 1997, 14:131-136.
23. Kandimalla K.K., Kanikkannan N., Singh M. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J. Control. Release 1999, 61:71-82.
24. Kleinebudde P. Use of a power-consumption-controlled extruder in the development of pellet formulations. J. Pharm. Sci. 1995, 84:1259-1264.
25. Mansa R.F., Bridson R.H., Greenwood R.W., Barker H., Seville J.P.K. Using intelligent software to predict the effects of formulation and processing parameters on roller compaction. Powder Technol. 2008, 181:217-225.
26. Mendyk, A., Dorożyński, P., Jachowicz, R., 2007. Proceedings of International Joint Conference on Neural Networks. Orlando, FL, USA, 12-17 August 2007. IJCNN, Orlando. IEEE Catalog Number: 07CH37922C, ISBN 1-04244-1380-X, ISSN 1098-7576.
27. Mendyk A., Jachowicz R. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst. Appl. 2007, 32:1124-1131.
28. Mendyk, A., Jachowicz, R., 2010. Decision support systems for pharmaceutical formulation development based on artificial neural networks. In: Jao, C.S. (Ed.), Decision Support Systems. Intech, Croatia. http://sciyo.com/books/show/title/decision-support-systems.
29. Peh K.K., Lim C.P., Quek S.S., Khoh K.H. Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor. Pharm. Res. 2000, 17:1384-1388.
30. Schmidt M.W., Baldridge K.K., Boatz J.A., Elbert S.T., Gordon M.S., Jensen J.H., Koseki S., Matsunaga N., Nguyen K.A., Su S.J., Windus T.L., Dupuis M., Montgomery J.A. General atomic and molecular electronic structure system. J. Comput. Chem. 1993, 14:1347-1363.
31. Takayama K., Fujikawa M., Nagai T. Artificial neural network as a novel method to optimize pharmaceutical formulation. Pharm. Res. 1999, 16:1-6.
32. Takayama K., Fujikawa M., Obata Y., Morishita M. Neural network based optimization of drug formulations. Adv. Drug Delivery Rev. 2003, 55:1217-1231.
33. Thommes M., Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur. J. Pharm. Biopharm. 2006, 63:68-75.
34. Thommes M., Kleinebudde P. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters. AAPS Pharm. Sci. Technol. 2007, 8:E95.
35. Thommes M., Kleinebudde P. Effect of drying pellets based on kappa-carrageenan on the dissolution behaviour. Eur. J. Pharm. Sci. 2007, 31:112-118.
36. Thommes M., Kleinebudde P. The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharm. Dev. Technol. 2008, 13:27-35.
37. Todeschini R., Consonni V. Handbook of Molecular Descriptors 2000, Wiley-VCH, Weinheim.
38. Türkoĝlu M., Özarslan R., Sakr A. Artificial neural network analysis of a direct compression tabletting study. Eur. J. Pharm. Biopharm. 1995, 41:315-322.
39. Veng-Pedersen P., Modi N.B. Application of neural networks to pharmacodynamics. J. Pharm. Sci. 1993, 82:1993.
40. Veng-Pedersen P., Modi N.B. Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?. J. Pharm. Biopharm. 1992, 20:1992.
41. Żurada, J.M., 1992. Introduction to Artificial Neural Systems. West Publishing Company, USA, Saint Paul Minnesota.
42. Żurada J.M., Malinowski A., Usui S. Perturbation method for deleting redundant inputs of perceptron networks. Neurocomputing 1997, 14:177-193.